The Effect of Mother's Gentle Human Touch Method on Preterm Pain and Mother's Anxiety Level During Venipuncture
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Feb 13, 2023
Trial Information
Current as of August 14, 2025
Completed
Keywords
ClinConnect Summary
June December 2021-Dec 2021, the universe of the research will consist of preterm infants and mothers admitted to Istanbul Zeynep Kamil Women and Children's Diseases Training and Research Hospital Neonatal Outpatient Clinic. The sample will be composed of mothers and preterm infants who have undergone bloodletting between these dates, who meet the sample selection criteria, and who volunteer to participate in the study Dec. At the beginning of the data collection phase, power analysis will be performed to determine the number of samples. Groups of babies will be determined using simple rand...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between 32 and 37 gestational weeks,
- • The first blood collection attempt is successful,
- • Health follow-ups performed after childbirth are considered healthy by the physician,
- Exclusion Criteria:
- • Analgesic given up to 6 hours before the procedure,
- • With a congenital anomaly, • With any disease,
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, üsküdar, Turkey
Istanbul, , Turkey
Patients applied
Trial Officials
DERYA KILINÇ, 1
Principal Investigator
ISTANBUL CERRAHPAŞA
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials